Use of lactoferrin for chronic hepatitis C

Hepatology Research

Volumn 32, Issue 4, 2005, Pages 200-201

  Kaito, Masahiko ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; LACTOFERRIN; RIBAVIRIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; CHRONIC HEPATITIS; CLINICAL TRIAL; COLOSTRUM; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG USE; EDITORIAL; HEPATITIS C VIRUS; HUMAN; IMMUNOMODULATION; MONOTHERAPY; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL;

EID: 23944507254     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.04.001     Document Type: Editorial

References (24)

1. M. Sørensen SPL. Sørensen The proteins in whey Copmt Rend Lab Carlsberg 23 1939 55-99
2. B. Johansson Isolation of an iron containing red protein from human milk Acta Chem Scand 14 1960 510-512
3. M.L. Groves The isolation of a red protein from milk J Am Chem Soc 82 1960 3345-3350
4. M.W. Rey SL. Woloshuk H.A. deBoer F.R. Pieper Complete nucleotide sequence of human mammary gland lactoferrin Nucleic Acids Res 18 1990 5288
5. A. Pierce D. Colavizza M. Benaissa et al. Molecular cloning and sequence analysis of bovine lactoferrin Eur J Biochem 1991 177-184
6. B.F. Anderson H.M. Baker G.E. Norris S.V. Rumball E.N. Baker Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins Nature 344 1990 784-787
7. P. Asien A. Leibman Lactoferrin and transferrin: A comparative study Biochem Biophys Acta 257 1972 314-323
8. W. Bellany M. Takase K. Yamauchi et al. Identification of the bactericidal domain of lactoferrin Biochem Biophys Acta 1121 1992 130-136
9. P.F. Levay M. Viljoen Lactoferrin: A general review Haematologica 80 1995 252-267
10. M. Ikeda K. Sugiyama T. Tanaka et al. Lactoferrin markedly inhibit hepatitis C virus infection in cultured human hepatocytes Biochem Biophys Res Commun 245 1998 549-553
11. M. Ikeda A. Nozaki K. Sugiyama et al. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells Virus Res 66 2000 51-63
12. Y. Matsuura H. Tani K. Suzuki et al. Characterization of pseudotype VSV possessing HCV envelope proteins Virology 286 2001 263-275
13. M. Yi S. Kaneko D.Y. Yu S. Murakami Hepatitis C virus envelope proteins bind lactoferrin J Virol 71 1997 5997-6002
14. A. Nozaki M. Ikeda A. Naganuma et al. Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein J Biol Chem 278 2003 10162-10173
15. K. Tanaka M. Ikeda A. Nozaki et al. Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: A pilot study Jpn J Cancer Res 90 1999 367-371
16. M. Iwasa M. Kaito J. Ikoma et al. Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b Am J Gastroenterol 97 2002 766-767
17. S. Okada K. Tanaka T. Sato et al. Dose-response trial of lactoferrin in patients with chronic hepatitis C Jpn J Cancer Res 93 2002 1063-1069
18. W.L. Hu J. Mazurier G. Sawatzki J. Montreuil G. Spike Lactotransferrin receptor of mouse small-intestinal brush border. Binding characteristics of membrane-bound and triton X-100-solubilized forms Biochem J 249 1988 435-441
19. Y.A. Suzuki K. Shin B. Lonnerdal Molecular cloning and functional expression of a human intestinal lactoferrin receptor Biochemistry 40 2001 15771-15779
20. M. Nakajima H. Iwamoto T. Shirasawa et al. Oral administration of lactoferrin enhances the production of IFN-γ and IL-10 in spleen cells cultured with concanavalin A or lipopolysaccharide Biomed Res 20 1999 27-33
21. T. Kuhara M. Iigo T. Ito et al. Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestine epithelium Natr Cancer 38 2000 192-199
22. K. Ishii N. Takamura M. Shinohara et al. Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months Hepatol Res 25 2003 226-233
23. N. Hirashima E. Orito K. Ohba et al. A randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral load Hepatol Res 29 2004 9-12
24. Y. Ishibashi K. Takeda N. Tsukidate et al. Randomized placebo-controlled trial of interferon alfa-2b plus ribavirin with and without lactoferrin for hepatitis C Hepatol Res 32 2005 218-223